Packaging	Usual price	Special price	You save
3 x 50 tabs (25 mg/tab)	225.00 EUR	213.00 EUR	12.00 EUR	(5%)	Out of stock
5 x 50 tabs (25 mg/tab)	375.00 EUR	356.00 EUR	19.00 EUR	(5%)	Out of stock
7 x 50 tabs (25 mg/tab)	525.00 EUR	472.00 EUR	53.00 EUR	(10%)	Out of stock

Description :

COMPOSITION 1 tablet Primobolan S contains metenolone acetate (17beta-hydroxy-1-methyl-5alpha-androst-1-en-3-one acetate) 25 mg.

PHARMACOLOGICAL ACTION In aplastic anaemias of various origins - both the idiopathic forms and those with exogenously damaged bone marrow - high doses of metenolone acetate may stimulate bone marrow function, particularly erythropoiesis. Metenolone acetate is a non-17alpha-alkylated.

INDICATIONS Aplastic anaemias.

CONTRA-INDICATIONS Primobolan S is contra-indicated in pregnancy as the metenolone acetate contained in the preparation, like all agents, possesses some androgenic activity which may lead to signs of virilisation in the female newborn. Because of this androgenic activity, Primobolan S is also contra-indicated in patients with prostatic carcinoma, since such substances may aggravate the disease.

DOSAGE AND DIRECTIONS FOR USE The therapy may have to be continued for at least 3 months at a dosage of 2-3 mg/kg bodyweight per day, ie 4-6 tablets for a person weighing 50 kg. Since some patients only respond after several months, treatment must not be stopped too soon. After improvement of the clinical picture treatment should, as a general rule, be continued for a further few weeks. Deterioration of the blood count after discontinuation of therapy may be reversed by renewed administration of Primobolan S.

SIDE EFFECTS AND SPECIAL PRECAUTIONS In female patients, signs of virilisation (acne, hirsutism, hoarseness, possibly irreversible deepening of the voice) must be reckoned with; in sexually mature women menstrual irregularities may occur. In adult males, spermatogenesis may be inhibited, in boys there may be signs of premature puberty. Non-adult patients should be monitored for accelerated bone maturation by X-ray. Impairment of liver function is less frequent than with a 17alpha-alkylated medicines. In men, regular examinations of the prostate should be carried out prophylactically to exclude a malignant tumour.